Laddar...
HE4 as a biomarker for ovarian and endometrial cancer management
Ovarian and endometrial cancer will be diagnosed in over 63,000 women in 2009, resulting in 22,000 deaths in the USA. Histologic screening, such as pap smears for detection of cervical cancer, is not feasible for these diseases given difficulty with access to the tissue. Thus, a serum-screening test...
Sparad:
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2009
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3273415/ https://ncbi.nlm.nih.gov/pubmed/19732003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/erm.09.39 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|